Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug based on CAR T-Cell Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CD19-targeted
1.2.3 BCMA-targeted
1.3 Market by Application
1.3.1 Global Drug based on CAR T-Cell Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Lymphoma
1.3.3 Multiple Myeloma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug based on CAR T-Cell Market Perspective (2018-2029)
2.2 Drug based on CAR T-Cell Growth Trends by Region
2.2.1 Global Drug based on CAR T-Cell Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug based on CAR T-Cell Historic Market Size by Region (2018-2024)
2.2.3 Drug based on CAR T-Cell Forecasted Market Size by Region (2024-2029)
2.3 Drug based on CAR T-Cell Market Dynamics
2.3.1 Drug based on CAR T-Cell Industry Trends
2.3.2 Drug based on CAR T-Cell Market Drivers
2.3.3 Drug based on CAR T-Cell Market Challenges
2.3.4 Drug based on CAR T-Cell Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug based on CAR T-Cell Players by Revenue
3.1.1 Global Top Drug based on CAR T-Cell Players by Revenue (2018-2024)
3.1.2 Global Drug based on CAR T-Cell Revenue Market Share by Players (2018-2024)
3.2 Global Drug based on CAR T-Cell Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug based on CAR T-Cell Revenue
3.4 Global Drug based on CAR T-Cell Market Concentration Ratio
3.4.1 Global Drug based on CAR T-Cell Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug based on CAR T-Cell Revenue in 2022
3.5 Drug based on CAR T-Cell Key Players Head office and Area Served
3.6 Key Players Drug based on CAR T-Cell Product Solution and Service
3.7 Date of Enter into Drug based on CAR T-Cell Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug based on CAR T-Cell Breakdown Data by Type
4.1 Global Drug based on CAR T-Cell Historic Market Size by Type (2018-2024)
4.2 Global Drug based on CAR T-Cell Forecasted Market Size by Type (2024-2029)
5 Drug based on CAR T-Cell Breakdown Data by Application
5.1 Global Drug based on CAR T-Cell Historic Market Size by Application (2018-2024)
5.2 Global Drug based on CAR T-Cell Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug based on CAR T-Cell Market Size (2018-2029)
6.2 North America Drug based on CAR T-Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug based on CAR T-Cell Market Size by Country (2018-2024)
6.4 North America Drug based on CAR T-Cell Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug based on CAR T-Cell Market Size (2018-2029)
7.2 Europe Drug based on CAR T-Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug based on CAR T-Cell Market Size by Country (2018-2024)
7.4 Europe Drug based on CAR T-Cell Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug based on CAR T-Cell Market Size (2018-2029)
8.2 Asia-Pacific Drug based on CAR T-Cell Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2018-2024)
8.4 Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug based on CAR T-Cell Market Size (2018-2029)
9.2 Latin America Drug based on CAR T-Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug based on CAR T-Cell Market Size by Country (2018-2024)
9.4 Latin America Drug based on CAR T-Cell Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug based on CAR T-Cell Market Size (2018-2029)
10.2 Middle East & Africa Drug based on CAR T-Cell Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2018-2024)
10.4 Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis
11.1.1 Novartis Company Detail
11.1.2 Novartis Business Overview
11.1.3 Novartis Drug based on CAR T-Cell Introduction
11.1.4 Novartis Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.1.5 Novartis Recent Development
11.2 Gilead Sciences
11.2.1 Gilead Sciences Company Detail
11.2.2 Gilead Sciences Business Overview
11.2.3 Gilead Sciences Drug based on CAR T-Cell Introduction
11.2.4 Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.2.5 Gilead Sciences Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Detail
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Drug based on CAR T-Cell Introduction
11.3.4 Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 J & J
11.4.1 J & J Company Detail
11.4.2 J & J Business Overview
11.4.3 J & J Drug based on CAR T-Cell Introduction
11.4.4 J & J Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.4.5 J & J Recent Development
11.5 JW Therapeutics
11.5.1 JW Therapeutics Company Detail
11.5.2 JW Therapeutics Business Overview
11.5.3 JW Therapeutics Drug based on CAR T-Cell Introduction
11.5.4 JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.5.5 JW Therapeutics Recent Development
11.6 FOSUNKite
11.6.1 FOSUNKite Company Detail
11.6.2 FOSUNKite Business Overview
11.6.3 FOSUNKite Drug based on CAR T-Cell Introduction
11.6.4 FOSUNKite Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.6.5 FOSUNKite Recent Development
11.7 CARsgen Therapeutics (Pipeline)
11.7.1 CARsgen Therapeutics (Pipeline) Company Detail
11.7.2 CARsgen Therapeutics (Pipeline) Business Overview
11.7.3 CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Introduction
11.7.4 CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.7.5 CARsgen Therapeutics (Pipeline) Recent Development
11.8 CARsgen Therapeutics
11.8.1 CARsgen Therapeutics Company Detail
11.8.2 CARsgen Therapeutics Business Overview
11.8.3 CARsgen Therapeutics Drug based on CAR T-Cell Introduction
11.8.4 CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.8.5 CARsgen Therapeutics Recent Development
11.9 Autolus Therapeutics
11.9.1 Autolus Therapeutics Company Detail
11.9.2 Autolus Therapeutics Business Overview
11.9.3 Autolus Therapeutics Drug based on CAR T-Cell Introduction
11.9.4 Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.9.5 Autolus Therapeutics Recent Development
11.10 Sorrento Therapeutics
11.10.1 Sorrento Therapeutics Company Detail
11.10.2 Sorrento Therapeutics Business Overview
11.10.3 Sorrento Therapeutics Drug based on CAR T-Cell Introduction
11.10.4 Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.10.5 Sorrento Therapeutics Recent Development
11.11 Mustang Bio
11.11.1 Mustang Bio Company Detail
11.11.2 Mustang Bio Business Overview
11.11.3 Mustang Bio Drug based on CAR T-Cell Introduction
11.11.4 Mustang Bio Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.11.5 Mustang Bio Recent Development
11.12 Bluebird Bio
11.12.1 Bluebird Bio Company Detail
11.12.2 Bluebird Bio Business Overview
11.12.3 Bluebird Bio Drug based on CAR T-Cell Introduction
11.12.4 Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.12.5 Bluebird Bio Recent Development
11.13 Cellectis
11.13.1 Cellectis Company Detail
11.13.2 Cellectis Business Overview
11.13.3 Cellectis Drug based on CAR T-Cell Introduction
11.13.4 Cellectis Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.13.5 Cellectis Recent Development
11.14 Allogene Therapeutics
11.14.1 Allogene Therapeutics Company Detail
11.14.2 Allogene Therapeutics Business Overview
11.14.3 Allogene Therapeutics Drug based on CAR T-Cell Introduction
11.14.4 Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.14.5 Allogene Therapeutics Recent Development
11.15 Celyad
11.15.1 Celyad Company Detail
11.15.2 Celyad Business Overview
11.15.3 Celyad Drug based on CAR T-Cell Introduction
11.15.4 Celyad Revenue in Drug based on CAR T-Cell Business (2018-2024)
11.15.5 Celyad Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Drug based on CAR T-Cell Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of CD19-targeted
Table 3. Key Players of BCMA-targeted
Table 4. Global Drug based on CAR T-Cell Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Drug based on CAR T-Cell Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Drug based on CAR T-Cell Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Drug based on CAR T-Cell Market Share by Region (2018-2024)
Table 8. Global Drug based on CAR T-Cell Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Drug based on CAR T-Cell Market Share by Region (2024-2029)
Table 10. Drug based on CAR T-Cell Market Trends
Table 11. Drug based on CAR T-Cell Market Drivers
Table 12. Drug based on CAR T-Cell Market Challenges
Table 13. Drug based on CAR T-Cell Market Restraints
Table 14. Global Drug based on CAR T-Cell Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Drug based on CAR T-Cell Market Share by Players (2018-2024)
Table 16. Global Top Drug based on CAR T-Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
Table 17. Ranking of Global Top Drug based on CAR T-Cell Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Drug based on CAR T-Cell Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Drug based on CAR T-Cell Product Solution and Service
Table 21. Date of Enter into Drug based on CAR T-Cell Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug based on CAR T-Cell Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Drug based on CAR T-Cell Revenue Market Share by Type (2018-2024)
Table 25. Global Drug based on CAR T-Cell Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Drug based on CAR T-Cell Revenue Market Share by Type (2024-2029)
Table 27. Global Drug based on CAR T-Cell Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Drug based on CAR T-Cell Revenue Market Share by Application (2018-2024)
Table 29. Global Drug based on CAR T-Cell Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Drug based on CAR T-Cell Revenue Market Share by Application (2024-2029)
Table 31. North America Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Drug based on CAR T-Cell Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Drug based on CAR T-Cell Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Drug based on CAR T-Cell Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Drug based on CAR T-Cell Market Size by Country (2024-2029) & (US$ Million)
Table 46. Novartis Company Detail
Table 47. Novartis Business Overview
Table 48. Novartis Drug based on CAR T-Cell Product
Table 49. Novartis Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 50. Novartis Recent Development
Table 51. Gilead Sciences Company Detail
Table 52. Gilead Sciences Business Overview
Table 53. Gilead Sciences Drug based on CAR T-Cell Product
Table 54. Gilead Sciences Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 55. Gilead Sciences Recent Development
Table 56. Bristol-Myers Squibb Company Detail
Table 57. Bristol-Myers Squibb Business Overview
Table 58. Bristol-Myers Squibb Drug based on CAR T-Cell Product
Table 59. Bristol-Myers Squibb Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 60. Bristol-Myers Squibb Recent Development
Table 61. J & J Company Detail
Table 62. J & J Business Overview
Table 63. J & J Drug based on CAR T-Cell Product
Table 64. J & J Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 65. J & J Recent Development
Table 66. JW Therapeutics Company Detail
Table 67. JW Therapeutics Business Overview
Table 68. JW Therapeutics Drug based on CAR T-Cell Product
Table 69. JW Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 70. JW Therapeutics Recent Development
Table 71. FOSUNKite Company Detail
Table 72. FOSUNKite Business Overview
Table 73. FOSUNKite Drug based on CAR T-Cell Product
Table 74. FOSUNKite Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 75. FOSUNKite Recent Development
Table 76. CARsgen Therapeutics (Pipeline) Company Detail
Table 77. CARsgen Therapeutics (Pipeline) Business Overview
Table 78. CARsgen Therapeutics (Pipeline) Drug based on CAR T-Cell Product
Table 79. CARsgen Therapeutics (Pipeline) Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 80. CARsgen Therapeutics (Pipeline) Recent Development
Table 81. CARsgen Therapeutics Company Detail
Table 82. CARsgen Therapeutics Business Overview
Table 83. CARsgen Therapeutics Drug based on CAR T-Cell Product
Table 84. CARsgen Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 85. CARsgen Therapeutics Recent Development
Table 86. Autolus Therapeutics Company Detail
Table 87. Autolus Therapeutics Business Overview
Table 88. Autolus Therapeutics Drug based on CAR T-Cell Product
Table 89. Autolus Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 90. Autolus Therapeutics Recent Development
Table 91. Sorrento Therapeutics Company Detail
Table 92. Sorrento Therapeutics Business Overview
Table 93. Sorrento Therapeutics Drug based on CAR T-Cell Product
Table 94. Sorrento Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 95. Sorrento Therapeutics Recent Development
Table 96. Mustang Bio Company Detail
Table 97. Mustang Bio Business Overview
Table 98. Mustang Bio Drug based on CAR T-Cell Product
Table 99. Mustang Bio Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 100. Mustang Bio Recent Development
Table 101. Bluebird Bio Company Detail
Table 102. Bluebird Bio Business Overview
Table 103. Bluebird Bio Drug based on CAR T-Cell Product
Table 104. Bluebird Bio Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 105. Bluebird Bio Recent Development
Table 106. Cellectis Company Detail
Table 107. Cellectis Business Overview
Table 108. Cellectis Drug based on CAR T-Cell Product
Table 109. Cellectis Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 110. Cellectis Recent Development
Table 111. Allogene Therapeutics Company Detail
Table 112. Allogene Therapeutics Business Overview
Table 113. Allogene Therapeutics Drug based on CAR T-Cell Product
Table 114. Allogene Therapeutics Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 115. Allogene Therapeutics Recent Development
Table 116. Celyad Company Detail
Table 117. Celyad Business Overview
Table 118. Celyad Drug based on CAR T-Cell Product
Table 119. Celyad Revenue in Drug based on CAR T-Cell Business (2018-2024) & (US$ Million)
Table 120. Celyad Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Drug based on CAR T-Cell Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Drug based on CAR T-Cell Market Share by Type: 2022 VS 2029
Figure 3. CD19-targeted Features
Figure 4. BCMA-targeted Features
Figure 5. Global Drug based on CAR T-Cell Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Drug based on CAR T-Cell Market Share by Application: 2022 VS 2029
Figure 7. Lymphoma Case Studies
Figure 8. Multiple Myeloma Case Studies
Figure 9. Drug based on CAR T-Cell Report Years Considered
Figure 10. Global Drug based on CAR T-Cell Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Drug based on CAR T-Cell Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Drug based on CAR T-Cell Market Share by Region: 2022 VS 2029
Figure 13. Global Drug based on CAR T-Cell Market Share by Players in 2022
Figure 14. Global Top Drug based on CAR T-Cell Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug based on CAR T-Cell as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Drug based on CAR T-Cell Revenue in 2022
Figure 16. North America Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 18. United States Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 22. Germany Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Drug based on CAR T-Cell Market Share by Region (2018-2029)
Figure 30. China Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 38. Mexico Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Drug based on CAR T-Cell Market Share by Country (2018-2029)
Figure 42. Turkey Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Drug based on CAR T-Cell Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Novartis Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 45. Gilead Sciences Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 46. Bristol-Myers Squibb Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 47. J & J Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 48. JW Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 49. FOSUNKite Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 50. CARsgen Therapeutics (Pipeline) Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 51. CARsgen Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 52. Autolus Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 53. Sorrento Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 54. Mustang Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 55. Bluebird Bio Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 56. Cellectis Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 57. Allogene Therapeutics Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 58. Celyad Revenue Growth Rate in Drug based on CAR T-Cell Business (2018-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed